Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by Markus Kimmann
Editorial: Three‐Dimensional (3D) Geometric Modelling in TIPS Implantation—A Further Step Toward Personalised Portal Pressure Reduction and Pre‐Procedural Planning. Authors' Reply
We would like to express our appreciation for the thoughtful and constructive editorial commentary by Zipprich and Ripoll [1] on our recent work [2]. We fully agree with the emphasised importance of recent advances in the personalization of treatment with TIPS (transjugular intrahepatic portosystemic shunt). Indeed, the field of TIPS has seen significant advances, particularly with the introduction of ePTFE-covered and controlled-expansion stents [3, 4].
Three‐Dimensional Transjugular Intrahepatic Portosystemic Shunt Geometry Predicts Shunt Dysfunction
2D (two dimensional) 3D (three dimensional) 95% CI (95% confidence interval) CT (computed tomography) CV (central venous) HE (hepatic encephalopathy) HR (hazard ratio) INR (international normalised ratio) IVC (inferior vena cava) MELD (model of end-stage liver disease) PSPG (portosystemic pressure gradient) PTFE (polytetrafluorethylene) PV (portal venous) TIPS (transjugular intrahepatic portosystemic shunt) VCX (VIATORR controlled expansion) VTS (VIATORR TIPS) 1 Introduction Liver cirrhosis...
Acute-On-Chronic Liver Failure: Current Interventional Treatment Options and Future Challenges
This is an early access version, the complete PDF, HTML, and XML versions will be available soon. Open AccessReview by Markus Kimmann 1,* and Jonel Trebicka 1,2,* 1 Department of Internal Medicine B, University of Münster, 48149 Münster, Germany 2 European Foundation for the Study of Chronic liver Failure, EFCLIF, 08021 Barcelona, Spain * Authors to whom correspondence should be addressed. J. Pers. Med.
Safety of Non-selective b-Blockers in Decompensated Cirrhosis
close Please confirm that you would like to log out of Medscape. If you log out, you will be required to enter your username and password the next time you visit. Log out Cancel In This Article Abstract and Introduction Abstract Background: The safety of non-selective β-blockers in patients with advanced cirrhosis has been questioned in recent years. It was hypothesised that there is a particular therapeutic window. However, the specific limits still need to be determined.
Systemic arterial blood pressure determines the therapeutic window of non‐selective beta blockers in decompensated cirrhosis - Tergast - - Alimentary Pharmacology & Therapeutics - Wiley Online Library
Summary Background The safety of non‐selective β‐blockers in patients with advanced cirrhosis has been questioned in recent years. It was hypothesised that there is a particular therapeutic window. However, the specific limits still need to be determined.
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Markus
Contact Markus, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack